nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC10—Vincristine—sarcoma	0.0593	0.0757	CbGbCtD
Verapamil—ABCC10—Etoposide—sarcoma	0.0543	0.0693	CbGbCtD
Verapamil—ABCC3—Vincristine—sarcoma	0.0373	0.0476	CbGbCtD
Verapamil—ABCC1—Dactinomycin—sarcoma	0.0372	0.0474	CbGbCtD
Verapamil—ABCC10—Doxorubicin—sarcoma	0.0371	0.0473	CbGbCtD
Verapamil—CYP2B6—Thiotepa—sarcoma	0.0364	0.0465	CbGbCtD
Verapamil—SLC22A5—Dactinomycin—sarcoma	0.0353	0.0451	CbGbCtD
Verapamil—ABCC3—Etoposide—sarcoma	0.0342	0.0436	CbGbCtD
Verapamil—ABCC1—Mitoxantrone—sarcoma	0.0333	0.0425	CbGbCtD
Verapamil—ABCB11—Vincristine—sarcoma	0.0322	0.0411	CbGbCtD
Verapamil—ABCC1—Epirubicin—sarcoma	0.0269	0.0344	CbGbCtD
Verapamil—ABCG2—Dactinomycin—sarcoma	0.0249	0.0317	CbGbCtD
Verapamil—ABCC3—Doxorubicin—sarcoma	0.0233	0.0297	CbGbCtD
Verapamil—ABCC1—Vincristine—sarcoma	0.0229	0.0292	CbGbCtD
Verapamil—ABCG2—Mitoxantrone—sarcoma	0.0223	0.0284	CbGbCtD
Verapamil—ABCC1—Etoposide—sarcoma	0.021	0.0268	CbGbCtD
Verapamil—ABCB11—Doxorubicin—sarcoma	0.0201	0.0257	CbGbCtD
Verapamil—ABCC2—Vincristine—sarcoma	0.0169	0.0216	CbGbCtD
Verapamil—ABCC2—Etoposide—sarcoma	0.0155	0.0198	CbGbCtD
Verapamil—ABCG2—Vincristine—sarcoma	0.0153	0.0196	CbGbCtD
Verapamil—ABCC1—Doxorubicin—sarcoma	0.0143	0.0183	CbGbCtD
Verapamil—ABCG2—Etoposide—sarcoma	0.014	0.0179	CbGbCtD
Verapamil—CYP1A2—Dacarbazine—sarcoma	0.0118	0.0151	CbGbCtD
Verapamil—CYP3A7—Vincristine—sarcoma	0.0113	0.0144	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0113	0.0144	CbGbCtD
Verapamil—CYP3A4—Thiotepa—sarcoma	0.0112	0.0143	CbGbCtD
Verapamil—ABCC2—Doxorubicin—sarcoma	0.0106	0.0135	CbGbCtD
Verapamil—CACNA1S—pes—sarcoma	0.0099	0.138	CbGeAlD
Verapamil—ABCG2—Doxorubicin—sarcoma	0.00958	0.0122	CbGbCtD
Verapamil—ABCB1—Dactinomycin—sarcoma	0.00897	0.0114	CbGbCtD
Verapamil—CYP3A5—Vincristine—sarcoma	0.00849	0.0108	CbGbCtD
Verapamil—ABCB1—Mitoxantrone—sarcoma	0.00803	0.0102	CbGbCtD
Verapamil—CYP3A5—Etoposide—sarcoma	0.00778	0.00993	CbGbCtD
Verapamil—CYP2C8—Etoposide—sarcoma	0.00748	0.00954	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—sarcoma	0.00673	0.00859	CbGbCtD
Verapamil—CYP1A2—Etoposide—sarcoma	0.00579	0.00739	CbGbCtD
Verapamil—ABCB1—Vincristine—sarcoma	0.00552	0.00705	CbGbCtD
Verapamil—ABCB1—Etoposide—sarcoma	0.00506	0.00646	CbGbCtD
Verapamil—CYP3A4—Mitoxantrone—sarcoma	0.00481	0.00614	CbGbCtD
Verapamil—ABCB1—Doxorubicin—sarcoma	0.00345	0.00441	CbGbCtD
Verapamil—CYP3A4—Vincristine—sarcoma	0.00331	0.00422	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—sarcoma	0.00325	0.00415	CbGbCtD
Verapamil—CYP3A4—Etoposide—sarcoma	0.00303	0.00387	CbGbCtD
Verapamil—SLC22A4—larynx—sarcoma	0.00239	0.0333	CbGeAlD
Verapamil—CYP3A4—Doxorubicin—sarcoma	0.00207	0.00264	CbGbCtD
Verapamil—CACNB3—mammary gland—sarcoma	0.00168	0.0234	CbGeAlD
Verapamil—CACNA1S—seminal vesicle—sarcoma	0.0012	0.0168	CbGeAlD
Verapamil—CACNA1B—connective tissue—sarcoma	0.0012	0.0167	CbGeAlD
Verapamil—CACNB3—myometrium—sarcoma	0.00119	0.0166	CbGeAlD
Verapamil—CACNB3—seminal vesicle—sarcoma	0.00108	0.015	CbGeAlD
Verapamil—KCNJ11—mammary gland—sarcoma	0.00107	0.0149	CbGeAlD
Verapamil—CACNA1I—testis—sarcoma	0.000891	0.0124	CbGeAlD
Verapamil—CACNB4—tendon—sarcoma	0.000885	0.0123	CbGeAlD
Verapamil—SLCO1B1—mammary gland—sarcoma	0.000874	0.0122	CbGeAlD
Verapamil—CACNA1H—myometrium—sarcoma	0.000849	0.0118	CbGeAlD
Verapamil—SLC22A4—mammary gland—sarcoma	0.000776	0.0108	CbGeAlD
Verapamil—CACNB3—uterus—sarcoma	0.000774	0.0108	CbGeAlD
Verapamil—CACNA1H—seminal vesicle—sarcoma	0.000767	0.0107	CbGeAlD
Verapamil—CACNA1S—tendon—sarcoma	0.000758	0.0105	CbGeAlD
Verapamil—CACNB4—testis—sarcoma	0.000733	0.0102	CbGeAlD
Verapamil—CACNB1—tendon—sarcoma	0.000707	0.00983	CbGeAlD
Verapamil—CACNA1A—testis—sarcoma	0.0007	0.00973	CbGeAlD
Verapamil—CACNA1B—testis—sarcoma	0.000683	0.0095	CbGeAlD
Verapamil—CACNB3—tendon—sarcoma	0.000678	0.00943	CbGeAlD
Verapamil—KCNJ11—hematopoietic system—sarcoma	0.000653	0.00908	CbGeAlD
Verapamil—CACNA1C—myometrium—sarcoma	0.000647	0.00899	CbGeAlD
Verapamil—CACNA1I—lymph node—sarcoma	0.000646	0.00898	CbGeAlD
Verapamil—CACNA1H—smooth muscle tissue—sarcoma	0.000642	0.00893	CbGeAlD
Verapamil—ABCC10—myometrium—sarcoma	0.000585	0.00814	CbGeAlD
Verapamil—CACNB1—testis—sarcoma	0.000585	0.00814	CbGeAlD
Verapamil—CACNB3—testis—sarcoma	0.000561	0.00781	CbGeAlD
Verapamil—CACNA1H—uterus—sarcoma	0.00055	0.00766	CbGeAlD
Verapamil—SLC22A4—myometrium—sarcoma	0.00055	0.00765	CbGeAlD
Verapamil—CACNA1C—connective tissue—sarcoma	0.000535	0.00744	CbGeAlD
Verapamil—SLCO1B1—hematopoietic system—sarcoma	0.000532	0.0074	CbGeAlD
Verapamil—ABCC10—seminal vesicle—sarcoma	0.000529	0.00736	CbGeAlD
Verapamil—CACNB2—cardiac atrium—sarcoma	0.000523	0.00727	CbGeAlD
Verapamil—SLC22A5—mammary gland—sarcoma	0.000513	0.00714	CbGeAlD
Verapamil—ABCC3—hematopoietic system—sarcoma	0.000505	0.00702	CbGeAlD
Verapamil—ABCC10—hematopoietic system—sarcoma	0.000503	0.00699	CbGeAlD
Verapamil—SLC22A4—seminal vesicle—sarcoma	0.000497	0.00691	CbGeAlD
Verapamil—CYP2C8—mammary gland—sarcoma	0.000497	0.00691	CbGeAlD
Verapamil—CACNA1B—lymph node—sarcoma	0.000495	0.00688	CbGeAlD
Verapamil—CACNA1C—smooth muscle tissue—sarcoma	0.000489	0.0068	CbGeAlD
Verapamil—KCNJ11—lymphoid tissue—sarcoma	0.00046	0.00639	CbGeAlD
Verapamil—CACNA1D—cardiac atrium—sarcoma	0.000457	0.00635	CbGeAlD
Verapamil—CACNB2—tendon—sarcoma	0.000455	0.00633	CbGeAlD
Verapamil—CYP2C9—mammary gland—sarcoma	0.000441	0.00614	CbGeAlD
Verapamil—ABCB11—testis—sarcoma	0.000435	0.00605	CbGeAlD
Verapamil—SLCO1A2—hematopoietic system—sarcoma	0.000433	0.00603	CbGeAlD
Verapamil—KCNJ11—tendon—sarcoma	0.000432	0.00601	CbGeAlD
Verapamil—CACNB1—lymph node—sarcoma	0.000424	0.0059	CbGeAlD
Verapamil—CYP2C18—liver—sarcoma	0.000423	0.00588	CbGeAlD
Verapamil—CACNA1C—cardiac atrium—sarcoma	0.000422	0.00586	CbGeAlD
Verapamil—SLC6A4—hematopoietic system—sarcoma	0.000419	0.00582	CbGeAlD
Verapamil—ABCC4—hematopoietic system—sarcoma	0.000417	0.0058	CbGeAlD
Verapamil—ABCC1—myometrium—sarcoma	0.000414	0.00576	CbGeAlD
Verapamil—ABCB11—liver—sarcoma	0.000411	0.00572	CbGeAlD
Verapamil—SCN5A—cardiac atrium—sarcoma	0.000409	0.00568	CbGeAlD
Verapamil—CACNB3—lymph node—sarcoma	0.000407	0.00566	CbGeAlD
Verapamil—CYP3A7—liver—sarcoma	0.000402	0.00559	CbGeAlD
Verapamil—CACNA1H—testis—sarcoma	0.000399	0.00555	CbGeAlD
Verapamil—KCNH2—myometrium—sarcoma	0.000385	0.00536	CbGeAlD
Verapamil—ABCC10—cardiac atrium—sarcoma	0.000382	0.00531	CbGeAlD
Verapamil—ABCC10—uterus—sarcoma	0.00038	0.00528	CbGeAlD
Verapamil—CACNA1H—liver—sarcoma	0.000378	0.00525	CbGeAlD
Verapamil—CACNB2—testis—sarcoma	0.000377	0.00524	CbGeAlD
Verapamil—ABCC1—seminal vesicle—sarcoma	0.000374	0.0052	CbGeAlD
Verapamil—SLC22A5—myometrium—sarcoma	0.000364	0.00506	CbGeAlD
Verapamil—CACNB2—liver—sarcoma	0.000357	0.00496	CbGeAlD
Verapamil—ABCC10—lymphoid tissue—sarcoma	0.000354	0.00492	CbGeAlD
Verapamil—KCNH2—seminal vesicle—sarcoma	0.000348	0.00484	CbGeAlD
Verapamil—CYP2C19—hematopoietic system—sarcoma	0.000347	0.00482	CbGeAlD
Verapamil—ABCG2—myometrium—sarcoma	0.000343	0.00477	CbGeAlD
Verapamil—CYP3A7-CYP3A51P—liver—sarcoma	0.000342	0.00476	CbGeAlD
Verapamil—ABCC10—tendon—sarcoma	0.000333	0.00463	CbGeAlD
Verapamil—KCNH2—hematopoietic system—sarcoma	0.000331	0.0046	CbGeAlD
Verapamil—CACNA1D—testis—sarcoma	0.00033	0.00458	CbGeAlD
Verapamil—SLC22A5—seminal vesicle—sarcoma	0.000329	0.00458	CbGeAlD
Verapamil—ABCC10—bone marrow—sarcoma	0.000322	0.00448	CbGeAlD
Verapamil—ABCC4—uterus—sarcoma	0.000315	0.00438	CbGeAlD
Verapamil—SLC22A4—tendon—sarcoma	0.000313	0.00435	CbGeAlD
Verapamil—CACNA1D—liver—sarcoma	0.000312	0.00433	CbGeAlD
Verapamil—ABCG2—seminal vesicle—sarcoma	0.00031	0.00431	CbGeAlD
Verapamil—CACNA1C—testis—sarcoma	0.000304	0.00423	CbGeAlD
Verapamil—SLC22A4—bone marrow—sarcoma	0.000303	0.00421	CbGeAlD
Verapamil—CYP2C8—hematopoietic system—sarcoma	0.000303	0.00421	CbGeAlD
Verapamil—CACNA1H—lymph node—sarcoma	0.000289	0.00403	CbGeAlD
Verapamil—CYP1A2—hematopoietic system—sarcoma	0.000283	0.00394	CbGeAlD
Verapamil—ABCC3—testis—sarcoma	0.000277	0.00385	CbGeAlD
Verapamil—ABCC4—tendon—sarcoma	0.000276	0.00384	CbGeAlD
Verapamil—SLCO1B1—liver—sarcoma	0.000276	0.00384	CbGeAlD
Verapamil—ABCC10—testis—sarcoma	0.000275	0.00383	CbGeAlD
Verapamil—CACNB2—lymph node—sarcoma	0.000273	0.0038	CbGeAlD
Verapamil—CYP3A5—hematopoietic system—sarcoma	0.000273	0.0038	CbGeAlD
Verapamil—SLC22A5—skin of body—sarcoma	0.000272	0.00378	CbGeAlD
Verapamil—CYP2B6—hematopoietic system—sarcoma	0.000272	0.00378	CbGeAlD
Verapamil—ABCC1—cardiac atrium—sarcoma	0.00027	0.00375	CbGeAlD
Verapamil—CYP2C9—hematopoietic system—sarcoma	0.000269	0.00374	CbGeAlD
Verapamil—ABCC1—uterus—sarcoma	0.000269	0.00373	CbGeAlD
Verapamil—ABCC4—bone marrow—sarcoma	0.000267	0.00372	CbGeAlD
Verapamil—ABCC2—tendon—sarcoma	0.000267	0.00371	CbGeAlD
Verapamil—ABCC3—liver—sarcoma	0.000262	0.00364	CbGeAlD
Verapamil—ABCC10—liver—sarcoma	0.00026	0.00362	CbGeAlD
Verapamil—KCNJ11—lymph node—sarcoma	0.000259	0.00361	CbGeAlD
Verapamil—KCNH2—cardiac atrium—sarcoma	0.000251	0.00349	CbGeAlD
Verapamil—KCNH2—uterus—sarcoma	0.00025	0.00348	CbGeAlD
Verapamil—Chest pain—Mitoxantrone—sarcoma	0.00024	0.00296	CcSEcCtD
Verapamil—Paraesthesia—Thiotepa—sarcoma	0.000239	0.00295	CcSEcCtD
Verapamil—CACNA1D—lymph node—sarcoma	0.000239	0.00332	CbGeAlD
Verapamil—Alopecia—Etoposide—sarcoma	0.000238	0.00294	CcSEcCtD
Verapamil—SLCO1A2—testis—sarcoma	0.000237	0.0033	CbGeAlD
Verapamil—SLC22A5—cardiac atrium—sarcoma	0.000237	0.0033	CbGeAlD
Verapamil—Discomfort—Mitoxantrone—sarcoma	0.000237	0.00292	CcSEcCtD
Verapamil—Somnolence—Thiotepa—sarcoma	0.000237	0.00292	CcSEcCtD
Verapamil—Oedema—Vincristine—sarcoma	0.000237	0.00291	CcSEcCtD
Verapamil—Anaphylactic shock—Vincristine—sarcoma	0.000237	0.00291	CcSEcCtD
Verapamil—CYP2B6—skin of body—sarcoma	0.000236	0.00328	CbGeAlD
Verapamil—ABCC1—tendon—sarcoma	0.000235	0.00327	CbGeAlD
Verapamil—Infection—Vincristine—sarcoma	0.000235	0.00289	CcSEcCtD
Verapamil—Dyspepsia—Thiotepa—sarcoma	0.000235	0.00289	CcSEcCtD
Verapamil—SLC22A1—liver—sarcoma	0.000233	0.00324	CbGeAlD
Verapamil—Confusional state—Mitoxantrone—sarcoma	0.000232	0.00286	CcSEcCtD
Verapamil—Anaphylactic shock—Mitoxantrone—sarcoma	0.00023	0.00284	CcSEcCtD
Verapamil—Oedema—Mitoxantrone—sarcoma	0.00023	0.00284	CcSEcCtD
Verapamil—Fatigue—Thiotepa—sarcoma	0.00023	0.00283	CcSEcCtD
Verapamil—Infection—Mitoxantrone—sarcoma	0.000229	0.00282	CcSEcCtD
Verapamil—Hyperhidrosis—Vincristine—sarcoma	0.000229	0.00282	CcSEcCtD
Verapamil—ABCC4—testis—sarcoma	0.000229	0.00318	CbGeAlD
Verapamil—Fatigue—Dactinomycin—sarcoma	0.000228	0.00281	CcSEcCtD
Verapamil—Constipation—Thiotepa—sarcoma	0.000228	0.00281	CcSEcCtD
Verapamil—Pain—Thiotepa—sarcoma	0.000228	0.00281	CcSEcCtD
Verapamil—Purpura—Epirubicin—sarcoma	0.000227	0.00279	CcSEcCtD
Verapamil—Shock—Mitoxantrone—sarcoma	0.000227	0.00279	CcSEcCtD
Verapamil—Pain—Dactinomycin—sarcoma	0.000226	0.00279	CcSEcCtD
Verapamil—Vascular purpura—Doxorubicin—sarcoma	0.000226	0.00278	CcSEcCtD
Verapamil—Muscle spasms—Etoposide—sarcoma	0.000226	0.00278	CcSEcCtD
Verapamil—Tachycardia—Mitoxantrone—sarcoma	0.000225	0.00277	CcSEcCtD
Verapamil—SLCO1A2—liver—sarcoma	0.000224	0.00312	CbGeAlD
Verapamil—Cardiac failure—Epirubicin—sarcoma	0.000224	0.00276	CcSEcCtD
Verapamil—Lethargy—Epirubicin—sarcoma	0.000223	0.00275	CcSEcCtD
Verapamil—Cerebrovascular accident—Epirubicin—sarcoma	0.000223	0.00275	CcSEcCtD
Verapamil—Hyperhidrosis—Mitoxantrone—sarcoma	0.000223	0.00274	CcSEcCtD
Verapamil—ABCG2—uterus—sarcoma	0.000222	0.00309	CbGeAlD
Verapamil—ABCC2—testis—sarcoma	0.000221	0.00308	CbGeAlD
Verapamil—Hypotension—Vincristine—sarcoma	0.000221	0.00272	CcSEcCtD
Verapamil—CACNA1C—lymph node—sarcoma	0.000221	0.00307	CbGeAlD
Verapamil—Feeling abnormal—Thiotepa—sarcoma	0.00022	0.00271	CcSEcCtD
Verapamil—Diplopia—Epirubicin—sarcoma	0.000218	0.00269	CcSEcCtD
Verapamil—Feeling abnormal—Dactinomycin—sarcoma	0.000218	0.00269	CcSEcCtD
Verapamil—ABCC4—liver—sarcoma	0.000216	0.003	CbGeAlD
Verapamil—Musculoskeletal discomfort—Vincristine—sarcoma	0.000215	0.00265	CcSEcCtD
Verapamil—Hypotension—Mitoxantrone—sarcoma	0.000215	0.00265	CcSEcCtD
Verapamil—Insomnia—Vincristine—sarcoma	0.000214	0.00263	CcSEcCtD
Verapamil—Paraesthesia—Vincristine—sarcoma	0.000212	0.00262	CcSEcCtD
Verapamil—KCNH2—bone marrow—sarcoma	0.000212	0.00295	CbGeAlD
Verapamil—Urticaria—Thiotepa—sarcoma	0.000212	0.00261	CcSEcCtD
Verapamil—Vertigo—Etoposide—sarcoma	0.000211	0.0026	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00021	0.00258	CcSEcCtD
Verapamil—Purpura—Doxorubicin—sarcoma	0.00021	0.00258	CcSEcCtD
Verapamil—ABCC2—liver—sarcoma	0.000209	0.00291	CbGeAlD
Verapamil—Cardiac arrest—Epirubicin—sarcoma	0.000208	0.00256	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—sarcoma	0.000207	0.00255	CcSEcCtD
Verapamil—SLC22A5—tendon—sarcoma	0.000207	0.00288	CbGeAlD
Verapamil—Paraesthesia—Mitoxantrone—sarcoma	0.000207	0.00255	CcSEcCtD
Verapamil—Loss of consciousness—Etoposide—sarcoma	0.000206	0.00254	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—sarcoma	0.000206	0.00254	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—sarcoma	0.000206	0.00254	CcSEcCtD
Verapamil—Dyspnoea—Mitoxantrone—sarcoma	0.000205	0.00253	CcSEcCtD
Verapamil—CYP3A4—hematopoietic system—sarcoma	0.000205	0.00285	CbGeAlD
Verapamil—Somnolence—Mitoxantrone—sarcoma	0.000205	0.00252	CcSEcCtD
Verapamil—Fatigue—Vincristine—sarcoma	0.000204	0.00251	CcSEcCtD
Verapamil—Convulsion—Etoposide—sarcoma	0.000203	0.00251	CcSEcCtD
Verapamil—Dyspepsia—Mitoxantrone—sarcoma	0.000203	0.0025	CcSEcCtD
Verapamil—Hypertension—Etoposide—sarcoma	0.000203	0.0025	CcSEcCtD
Verapamil—Constipation—Vincristine—sarcoma	0.000202	0.00249	CcSEcCtD
Verapamil—Pain—Vincristine—sarcoma	0.000202	0.00249	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—sarcoma	0.000202	0.00249	CcSEcCtD
Verapamil—CYP2D6—hematopoietic system—sarcoma	0.000202	0.00281	CbGeAlD
Verapamil—ABCC3—lymph node—sarcoma	0.000201	0.00279	CbGeAlD
Verapamil—Chest pain—Etoposide—sarcoma	0.0002	0.00246	CcSEcCtD
Verapamil—ABCC10—lymph node—sarcoma	0.0002	0.00278	CbGeAlD
Verapamil—Orthostatic hypotension—Epirubicin—sarcoma	0.0002	0.00246	CcSEcCtD
Verapamil—Fatigue—Mitoxantrone—sarcoma	0.000199	0.00245	CcSEcCtD
Verapamil—Discomfort—Etoposide—sarcoma	0.000197	0.00243	CcSEcCtD
Verapamil—Pain—Mitoxantrone—sarcoma	0.000197	0.00243	CcSEcCtD
Verapamil—Constipation—Mitoxantrone—sarcoma	0.000197	0.00243	CcSEcCtD
Verapamil—Hypersensitivity—Thiotepa—sarcoma	0.000196	0.00242	CcSEcCtD
Verapamil—Hypersensitivity—Dactinomycin—sarcoma	0.000195	0.0024	CcSEcCtD
Verapamil—ABCC1—testis—sarcoma	0.000195	0.00271	CbGeAlD
Verapamil—Confusional state—Etoposide—sarcoma	0.000193	0.00238	CcSEcCtD
Verapamil—Muscular weakness—Epirubicin—sarcoma	0.000193	0.00237	CcSEcCtD
Verapamil—Cardiac arrest—Doxorubicin—sarcoma	0.000192	0.00237	CcSEcCtD
Verapamil—Anaphylactic shock—Etoposide—sarcoma	0.000192	0.00236	CcSEcCtD
Verapamil—Asthenia—Thiotepa—sarcoma	0.000191	0.00236	CcSEcCtD
Verapamil—CYP2B6—lymphoid tissue—sarcoma	0.000191	0.00266	CbGeAlD
Verapamil—Infection—Etoposide—sarcoma	0.00019	0.00234	CcSEcCtD
Verapamil—Asthenia—Dactinomycin—sarcoma	0.00019	0.00234	CcSEcCtD
Verapamil—Feeling abnormal—Mitoxantrone—sarcoma	0.00019	0.00234	CcSEcCtD
Verapamil—Influenza—Epirubicin—sarcoma	0.000189	0.00233	CcSEcCtD
Verapamil—Pruritus—Thiotepa—sarcoma	0.000189	0.00232	CcSEcCtD
Verapamil—ABCG2—bone marrow—sarcoma	0.000189	0.00262	CbGeAlD
Verapamil—SLC22A4—lymph node—sarcoma	0.000188	0.00261	CbGeAlD
Verapamil—Tachycardia—Etoposide—sarcoma	0.000187	0.0023	CcSEcCtD
Verapamil—Hyperhidrosis—Etoposide—sarcoma	0.000185	0.00228	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—sarcoma	0.000185	0.00227	CcSEcCtD
Verapamil—ABCC1—liver—sarcoma	0.000184	0.00256	CbGeAlD
Verapamil—Angina pectoris—Epirubicin—sarcoma	0.000184	0.00227	CcSEcCtD
Verapamil—Urticaria—Mitoxantrone—sarcoma	0.000183	0.00225	CcSEcCtD
Verapamil—Diarrhoea—Thiotepa—sarcoma	0.000182	0.00225	CcSEcCtD
Verapamil—KCNH2—testis—sarcoma	0.000181	0.00252	CbGeAlD
Verapamil—Diarrhoea—Dactinomycin—sarcoma	0.000181	0.00223	CcSEcCtD
Verapamil—CYP2C19—liver—sarcoma	0.00018	0.0025	CbGeAlD
Verapamil—Hypotension—Etoposide—sarcoma	0.000179	0.0022	CcSEcCtD
Verapamil—Muscular weakness—Doxorubicin—sarcoma	0.000178	0.0022	CcSEcCtD
Verapamil—Dizziness—Thiotepa—sarcoma	0.000176	0.00217	CcSEcCtD
Verapamil—Upper respiratory tract infection—Epirubicin—sarcoma	0.000176	0.00216	CcSEcCtD
Verapamil—Influenza—Doxorubicin—sarcoma	0.000175	0.00215	CcSEcCtD
Verapamil—Pollakiuria—Epirubicin—sarcoma	0.000174	0.00215	CcSEcCtD
Verapamil—Hypersensitivity—Vincristine—sarcoma	0.000174	0.00215	CcSEcCtD
Verapamil—Paraesthesia—Etoposide—sarcoma	0.000172	0.00212	CcSEcCtD
Verapamil—SLC22A5—testis—sarcoma	0.000171	0.00238	CbGeAlD
Verapamil—Dyspnoea—Etoposide—sarcoma	0.000171	0.0021	CcSEcCtD
Verapamil—Somnolence—Etoposide—sarcoma	0.00017	0.0021	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—sarcoma	0.00017	0.0021	CcSEcCtD
Verapamil—Hypersensitivity—Mitoxantrone—sarcoma	0.00017	0.00209	CcSEcCtD
Verapamil—Asthenia—Vincristine—sarcoma	0.00017	0.00209	CcSEcCtD
Verapamil—Vomiting—Thiotepa—sarcoma	0.00017	0.00209	CcSEcCtD
Verapamil—ABCB1—myometrium—sarcoma	0.000169	0.00235	CbGeAlD
Verapamil—Drowsiness—Epirubicin—sarcoma	0.000168	0.00207	CcSEcCtD
Verapamil—Vomiting—Dactinomycin—sarcoma	0.000168	0.00207	CcSEcCtD
Verapamil—Rash—Thiotepa—sarcoma	0.000168	0.00207	CcSEcCtD
Verapamil—Dermatitis—Thiotepa—sarcoma	0.000168	0.00207	CcSEcCtD
Verapamil—Headache—Thiotepa—sarcoma	0.000167	0.00206	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000167	0.00206	CcSEcCtD
Verapamil—Rash—Dactinomycin—sarcoma	0.000167	0.00206	CcSEcCtD
Verapamil—CYP2C8—testis—sarcoma	0.000166	0.00231	CbGeAlD
Verapamil—ABCC4—lymph node—sarcoma	0.000166	0.0023	CbGeAlD
Verapamil—Asthenia—Mitoxantrone—sarcoma	0.000165	0.00204	CcSEcCtD
Verapamil—Fatigue—Etoposide—sarcoma	0.000165	0.00203	CcSEcCtD
Verapamil—Jaundice—Epirubicin—sarcoma	0.000164	0.00202	CcSEcCtD
Verapamil—Constipation—Etoposide—sarcoma	0.000164	0.00202	CcSEcCtD
Verapamil—Pain—Etoposide—sarcoma	0.000164	0.00202	CcSEcCtD
Verapamil—ABCB1—embryo—sarcoma	0.000163	0.00226	CbGeAlD
Verapamil—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000162	0.002	CcSEcCtD
Verapamil—SLC22A5—liver—sarcoma	0.000162	0.00225	CbGeAlD
Verapamil—Diarrhoea—Vincristine—sarcoma	0.000162	0.00199	CcSEcCtD
Verapamil—Sweating—Epirubicin—sarcoma	0.000161	0.00199	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—sarcoma	0.000161	0.00199	CcSEcCtD
Verapamil—ABCG2—testis—sarcoma	0.000161	0.00224	CbGeAlD
Verapamil—ABCC2—lymph node—sarcoma	0.00016	0.00223	CbGeAlD
Verapamil—Nausea—Thiotepa—sarcoma	0.000158	0.00195	CcSEcCtD
Verapamil—Sinusitis—Epirubicin—sarcoma	0.000158	0.00195	CcSEcCtD
Verapamil—Feeling abnormal—Etoposide—sarcoma	0.000158	0.00194	CcSEcCtD
Verapamil—Diarrhoea—Mitoxantrone—sarcoma	0.000158	0.00194	CcSEcCtD
Verapamil—Nausea—Dactinomycin—sarcoma	0.000157	0.00194	CcSEcCtD
Verapamil—CYP2C8—liver—sarcoma	0.000157	0.00218	CbGeAlD
Verapamil—Dizziness—Vincristine—sarcoma	0.000156	0.00193	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—sarcoma	0.000156	0.00192	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000154	0.0019	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—sarcoma	0.000154	0.0019	CcSEcCtD
Verapamil—ABCB1—seminal vesicle—sarcoma	0.000153	0.00212	CbGeAlD
Verapamil—ABCG2—liver—sarcoma	0.000152	0.00212	CbGeAlD
Verapamil—Urticaria—Etoposide—sarcoma	0.000152	0.00187	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—sarcoma	0.000152	0.00187	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—sarcoma	0.000152	0.00187	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—sarcoma	0.000151	0.00186	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—sarcoma	0.00015	0.00185	CcSEcCtD
Verapamil—Vomiting—Vincristine—sarcoma	0.00015	0.00185	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—sarcoma	0.00015	0.00185	CcSEcCtD
Verapamil—Sweating—Doxorubicin—sarcoma	0.000149	0.00184	CcSEcCtD
Verapamil—Rash—Vincristine—sarcoma	0.000149	0.00184	CcSEcCtD
Verapamil—Dermatitis—Vincristine—sarcoma	0.000149	0.00184	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—sarcoma	0.000149	0.00183	CcSEcCtD
Verapamil—CYP2B6—testis—sarcoma	0.000149	0.00207	CbGeAlD
Verapamil—Headache—Vincristine—sarcoma	0.000148	0.00182	CcSEcCtD
Verapamil—CYP1A2—liver—sarcoma	0.000147	0.00204	CbGeAlD
Verapamil—Vomiting—Mitoxantrone—sarcoma	0.000146	0.0018	CcSEcCtD
Verapamil—Sinusitis—Doxorubicin—sarcoma	0.000146	0.0018	CcSEcCtD
Verapamil—Visual impairment—Epirubicin—sarcoma	0.000146	0.00179	CcSEcCtD
Verapamil—Rash—Mitoxantrone—sarcoma	0.000145	0.00179	CcSEcCtD
Verapamil—ABCB1—hematopoietic system—sarcoma	0.000145	0.00202	CbGeAlD
Verapamil—Dermatitis—Mitoxantrone—sarcoma	0.000145	0.00179	CcSEcCtD
Verapamil—Headache—Mitoxantrone—sarcoma	0.000144	0.00178	CcSEcCtD
Verapamil—Erythema multiforme—Epirubicin—sarcoma	0.000143	0.00176	CcSEcCtD
Verapamil—Bradycardia—Doxorubicin—sarcoma	0.000142	0.00175	CcSEcCtD
Verapamil—CYP3A5—liver—sarcoma	0.000142	0.00197	CbGeAlD
Verapamil—ABCC1—lymph node—sarcoma	0.000141	0.00196	CbGeAlD
Verapamil—Hypersensitivity—Etoposide—sarcoma	0.000141	0.00174	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—sarcoma	0.000141	0.00174	CcSEcCtD
Verapamil—CYP2B6—liver—sarcoma	0.000141	0.00196	CbGeAlD
Verapamil—Nausea—Vincristine—sarcoma	0.00014	0.00173	CcSEcCtD
Verapamil—Flushing—Epirubicin—sarcoma	0.00014	0.00173	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—sarcoma	0.00014	0.00173	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—sarcoma	0.00014	0.00172	CcSEcCtD
Verapamil—CYP2C9—liver—sarcoma	0.000139	0.00194	CbGeAlD
Verapamil—Hypoaesthesia—Doxorubicin—sarcoma	0.000139	0.00171	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—sarcoma	0.000139	0.00171	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—sarcoma	0.000138	0.0017	CcSEcCtD
Verapamil—Asthenia—Etoposide—sarcoma	0.000137	0.00169	CcSEcCtD
Verapamil—Nausea—Mitoxantrone—sarcoma	0.000137	0.00169	CcSEcCtD
Verapamil—Pruritus—Etoposide—sarcoma	0.000136	0.00167	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—sarcoma	0.000135	0.00166	CcSEcCtD
Verapamil—Alopecia—Epirubicin—sarcoma	0.000134	0.00165	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—sarcoma	0.000132	0.00163	CcSEcCtD
Verapamil—KCNH2—lymph node—sarcoma	0.000131	0.00183	CbGeAlD
Verapamil—Diarrhoea—Etoposide—sarcoma	0.000131	0.00161	CcSEcCtD
Verapamil—Tinnitus—Doxorubicin—sarcoma	0.00013	0.00161	CcSEcCtD
Verapamil—Flushing—Doxorubicin—sarcoma	0.00013	0.0016	CcSEcCtD
Verapamil—Dizziness—Etoposide—sarcoma	0.000127	0.00156	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—sarcoma	0.000127	0.00156	CcSEcCtD
Verapamil—SLC22A5—lymph node—sarcoma	0.000124	0.00173	CbGeAlD
Verapamil—Vision blurred—Epirubicin—sarcoma	0.000124	0.00153	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—sarcoma	0.000124	0.00152	CcSEcCtD
Verapamil—Vomiting—Etoposide—sarcoma	0.000122	0.0015	CcSEcCtD
Verapamil—Agitation—Epirubicin—sarcoma	0.000121	0.00149	CcSEcCtD
Verapamil—Rash—Etoposide—sarcoma	0.000121	0.00149	CcSEcCtD
Verapamil—Dermatitis—Etoposide—sarcoma	0.000121	0.00149	CcSEcCtD
Verapamil—Headache—Etoposide—sarcoma	0.00012	0.00148	CcSEcCtD
Verapamil—Vertigo—Epirubicin—sarcoma	0.000118	0.00146	CcSEcCtD
Verapamil—Syncope—Epirubicin—sarcoma	0.000118	0.00145	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—sarcoma	0.000117	0.00144	CcSEcCtD
Verapamil—ABCG2—lymph node—sarcoma	0.000117	0.00163	CbGeAlD
Verapamil—Palpitations—Epirubicin—sarcoma	0.000116	0.00143	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—sarcoma	0.000116	0.00142	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—sarcoma	0.000115	0.00141	CcSEcCtD
Verapamil—Convulsion—Epirubicin—sarcoma	0.000114	0.0014	CcSEcCtD
Verapamil—Nausea—Etoposide—sarcoma	0.000114	0.0014	CcSEcCtD
Verapamil—Hypertension—Epirubicin—sarcoma	0.000114	0.0014	CcSEcCtD
Verapamil—Chest pain—Epirubicin—sarcoma	0.000112	0.00138	CcSEcCtD
Verapamil—Myalgia—Epirubicin—sarcoma	0.000112	0.00138	CcSEcCtD
Verapamil—Arthralgia—Epirubicin—sarcoma	0.000112	0.00138	CcSEcCtD
Verapamil—Agitation—Doxorubicin—sarcoma	0.000112	0.00138	CcSEcCtD
Verapamil—Discomfort—Epirubicin—sarcoma	0.000111	0.00136	CcSEcCtD
Verapamil—CYP2D6—testis—sarcoma	0.000111	0.00154	CbGeAlD
Verapamil—ABCB1—uterus—sarcoma	0.00011	0.00152	CbGeAlD
Verapamil—Dry mouth—Epirubicin—sarcoma	0.00011	0.00135	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—sarcoma	0.000109	0.00135	CcSEcCtD
Verapamil—Syncope—Doxorubicin—sarcoma	0.000109	0.00134	CcSEcCtD
Verapamil—Confusional state—Epirubicin—sarcoma	0.000108	0.00133	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—sarcoma	0.000108	0.00133	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—sarcoma	0.000107	0.00132	CcSEcCtD
Verapamil—Oedema—Epirubicin—sarcoma	0.000107	0.00132	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—sarcoma	0.000107	0.00132	CcSEcCtD
Verapamil—Infection—Epirubicin—sarcoma	0.000107	0.00131	CcSEcCtD
Verapamil—CYP3A4—liver—sarcoma	0.000106	0.00148	CbGeAlD
Verapamil—Shock—Epirubicin—sarcoma	0.000106	0.0013	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—sarcoma	0.000105	0.0013	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—sarcoma	0.000105	0.00129	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—sarcoma	0.000105	0.00129	CcSEcCtD
Verapamil—CYP2D6—liver—sarcoma	0.000105	0.00145	CbGeAlD
Verapamil—Hyperhidrosis—Epirubicin—sarcoma	0.000104	0.00128	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—sarcoma	0.000104	0.00128	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—sarcoma	0.000104	0.00128	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—sarcoma	0.000104	0.00128	CcSEcCtD
Verapamil—Discomfort—Doxorubicin—sarcoma	0.000102	0.00126	CcSEcCtD
Verapamil—ABCB1—lymphoid tissue—sarcoma	0.000102	0.00142	CbGeAlD
Verapamil—Dry mouth—Doxorubicin—sarcoma	0.000101	0.00125	CcSEcCtD
Verapamil—Hypotension—Epirubicin—sarcoma	0.0001	0.00124	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—sarcoma	0.0001	0.00123	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—sarcoma	9.94e-05	0.00122	CcSEcCtD
Verapamil—Oedema—Doxorubicin—sarcoma	9.94e-05	0.00122	CcSEcCtD
Verapamil—Infection—Doxorubicin—sarcoma	9.87e-05	0.00122	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—sarcoma	9.78e-05	0.00121	CcSEcCtD
Verapamil—Shock—Doxorubicin—sarcoma	9.78e-05	0.0012	CcSEcCtD
Verapamil—Insomnia—Epirubicin—sarcoma	9.71e-05	0.0012	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—sarcoma	9.7e-05	0.00119	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—sarcoma	9.64e-05	0.00119	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—sarcoma	9.61e-05	0.00118	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—sarcoma	9.57e-05	0.00118	CcSEcCtD
Verapamil—Somnolence—Epirubicin—sarcoma	9.55e-05	0.00118	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—sarcoma	9.45e-05	0.00116	CcSEcCtD
Verapamil—ABCB1—bone marrow—sarcoma	9.3e-05	0.00129	CbGeAlD
Verapamil—Hypotension—Doxorubicin—sarcoma	9.29e-05	0.00114	CcSEcCtD
Verapamil—Fatigue—Epirubicin—sarcoma	9.26e-05	0.00114	CcSEcCtD
Verapamil—Constipation—Epirubicin—sarcoma	9.18e-05	0.00113	CcSEcCtD
Verapamil—Pain—Epirubicin—sarcoma	9.18e-05	0.00113	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—sarcoma	9.05e-05	0.00112	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—sarcoma	8.99e-05	0.00111	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—sarcoma	8.92e-05	0.0011	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—sarcoma	8.86e-05	0.00109	CcSEcCtD
Verapamil—Feeling abnormal—Epirubicin—sarcoma	8.85e-05	0.00109	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—sarcoma	8.83e-05	0.00109	CcSEcCtD
Verapamil—Dyspepsia—Doxorubicin—sarcoma	8.75e-05	0.00108	CcSEcCtD
Verapamil—Fatigue—Doxorubicin—sarcoma	8.57e-05	0.00106	CcSEcCtD
Verapamil—Urticaria—Epirubicin—sarcoma	8.53e-05	0.00105	CcSEcCtD
Verapamil—Pain—Doxorubicin—sarcoma	8.5e-05	0.00105	CcSEcCtD
Verapamil—Constipation—Doxorubicin—sarcoma	8.5e-05	0.00105	CcSEcCtD
Verapamil—Feeling abnormal—Doxorubicin—sarcoma	8.19e-05	0.00101	CcSEcCtD
Verapamil—ABCB1—testis—sarcoma	7.95e-05	0.00111	CbGeAlD
Verapamil—Hypersensitivity—Epirubicin—sarcoma	7.91e-05	0.000975	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—sarcoma	7.89e-05	0.000972	CcSEcCtD
Verapamil—Asthenia—Epirubicin—sarcoma	7.71e-05	0.000949	CcSEcCtD
Verapamil—Pruritus—Epirubicin—sarcoma	7.6e-05	0.000936	CcSEcCtD
Verapamil—ABCB1—liver—sarcoma	7.52e-05	0.00105	CbGeAlD
Verapamil—Diarrhoea—Epirubicin—sarcoma	7.35e-05	0.000905	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—sarcoma	7.32e-05	0.000902	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—sarcoma	7.13e-05	0.000878	CcSEcCtD
Verapamil—Dizziness—Epirubicin—sarcoma	7.1e-05	0.000875	CcSEcCtD
Verapamil—Pruritus—Doxorubicin—sarcoma	7.03e-05	0.000866	CcSEcCtD
Verapamil—Vomiting—Epirubicin—sarcoma	6.83e-05	0.000841	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—sarcoma	6.8e-05	0.000837	CcSEcCtD
Verapamil—Rash—Epirubicin—sarcoma	6.77e-05	0.000834	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—sarcoma	6.76e-05	0.000833	CcSEcCtD
Verapamil—Headache—Epirubicin—sarcoma	6.73e-05	0.000829	CcSEcCtD
Verapamil—Dizziness—Doxorubicin—sarcoma	6.57e-05	0.000809	CcSEcCtD
Verapamil—Nausea—Epirubicin—sarcoma	6.38e-05	0.000786	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—sarcoma	6.32e-05	0.000778	CcSEcCtD
Verapamil—Rash—Doxorubicin—sarcoma	6.27e-05	0.000772	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—sarcoma	6.26e-05	0.000771	CcSEcCtD
Verapamil—Headache—Doxorubicin—sarcoma	6.22e-05	0.000767	CcSEcCtD
Verapamil—Nausea—Doxorubicin—sarcoma	5.9e-05	0.000727	CcSEcCtD
Verapamil—ABCB1—lymph node—sarcoma	5.77e-05	0.000802	CbGeAlD
Verapamil—CACNA1H—Axon guidance—EGFR—sarcoma	3.93e-05	0.000622	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—EGFR—sarcoma	3.93e-05	0.000621	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MMP2—sarcoma	3.92e-05	0.00062	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—MMP2—sarcoma	3.92e-05	0.00062	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—JUN—sarcoma	3.91e-05	0.000619	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—KDR—sarcoma	3.9e-05	0.000616	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	3.85e-05	0.000608	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—MDM2—sarcoma	3.85e-05	0.000608	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—KRAS—sarcoma	3.84e-05	0.000606	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—SRC—sarcoma	3.81e-05	0.000603	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—SRC—sarcoma	3.81e-05	0.000602	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—HRAS—sarcoma	3.76e-05	0.000595	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—KRAS—sarcoma	3.71e-05	0.000587	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—VEGFA—sarcoma	3.71e-05	0.000587	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—KRAS—sarcoma	3.71e-05	0.000587	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—SRC—sarcoma	3.71e-05	0.000586	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—VEGFA—sarcoma	3.71e-05	0.000586	CbGpPWpGaD
Verapamil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	3.68e-05	0.000582	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—NRAS—sarcoma	3.67e-05	0.00058	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—NRAS—sarcoma	3.66e-05	0.000579	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—HRAS—sarcoma	3.66e-05	0.000578	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—CTNNB1—sarcoma	3.66e-05	0.000578	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—VEGFA—sarcoma	3.61e-05	0.000571	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	3.61e-05	0.000571	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—CREB1—sarcoma	3.61e-05	0.000571	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—NRAS—sarcoma	3.57e-05	0.000564	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—IL2—sarcoma	3.56e-05	0.000563	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—CTNNB1—sarcoma	3.54e-05	0.00056	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—CREB1—sarcoma	3.53e-05	0.000558	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—KDR—sarcoma	3.46e-05	0.000547	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	3.45e-05	0.000546	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	3.45e-05	0.000546	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—KDR—sarcoma	3.43e-05	0.000542	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—CREB1—sarcoma	3.42e-05	0.000541	CbGpPWpGaD
Verapamil—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	3.42e-05	0.00054	CbGpPWpGaD
Verapamil—CACNB2—Transmission across Chemical Synapses—HRAS—sarcoma	3.38e-05	0.000534	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	3.36e-05	0.000532	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MMP2—sarcoma	3.36e-05	0.000531	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—HRAS—sarcoma	3.36e-05	0.000531	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—EGFR—sarcoma	3.34e-05	0.000528	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—EGFR—sarcoma	3.34e-05	0.000528	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	3.32e-05	0.000525	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—SRC—sarcoma	3.31e-05	0.000523	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ENO2—sarcoma	3.29e-05	0.00052	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—HBA1—sarcoma	3.27e-05	0.000517	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—SRC—sarcoma	3.26e-05	0.000516	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—HRAS—sarcoma	3.26e-05	0.000515	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—EGFR—sarcoma	3.25e-05	0.000514	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—VEGFA—sarcoma	3.22e-05	0.000509	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—IL2—sarcoma	3.21e-05	0.000508	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—SRC—sarcoma	3.2e-05	0.000506	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MMP2—sarcoma	3.18e-05	0.000503	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—NRAS—sarcoma	3.18e-05	0.000503	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—VEGFA—sarcoma	3.18e-05	0.000503	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—HRAS—sarcoma	3.16e-05	0.000499	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—KRAS—sarcoma	3.16e-05	0.000499	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—HRAS—sarcoma	3.16e-05	0.000499	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	3.15e-05	0.000499	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—KRAS—sarcoma	3.15e-05	0.000498	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—NRAS—sarcoma	3.14e-05	0.000496	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ENO2—sarcoma	3.14e-05	0.000496	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—VEGFA—sarcoma	3.12e-05	0.000493	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—HBA1—sarcoma	3.12e-05	0.000493	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ENO2—sarcoma	3.11e-05	0.000492	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—SRC—sarcoma	3.11e-05	0.000491	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—HBA1—sarcoma	3.09e-05	0.000489	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	3.09e-05	0.000489	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—SRC—sarcoma	3.09e-05	0.000489	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—NRAS—sarcoma	3.08e-05	0.000487	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—KRAS—sarcoma	3.07e-05	0.000486	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—CREB1—sarcoma	3.04e-05	0.00048	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—sarcoma	3.03e-05	0.000478	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	3.03e-05	0.000478	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	3.03e-05	0.000478	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—VEGFA—sarcoma	3.01e-05	0.000476	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—CTNNB1—sarcoma	3.01e-05	0.000475	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—CREB1—sarcoma	3e-05	0.000475	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—NRAS—sarcoma	2.97e-05	0.00047	CbGpPWpGaD
Verapamil—ABCC1—Disease—TLE1—sarcoma	2.94e-05	0.000464	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—MDM2—sarcoma	2.92e-05	0.000462	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	2.91e-05	0.00046	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—EGFR—sarcoma	2.9e-05	0.000458	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—EGFR—sarcoma	2.86e-05	0.000452	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	2.86e-05	0.000452	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MMP2—sarcoma	2.83e-05	0.000447	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—EGFR—sarcoma	2.81e-05	0.000444	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MMP2—sarcoma	2.8e-05	0.000442	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PLCG1—sarcoma	2.79e-05	0.000441	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—SRC—sarcoma	2.74e-05	0.000434	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—KRAS—sarcoma	2.74e-05	0.000433	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ENO2—sarcoma	2.74e-05	0.000433	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—VEGFA—sarcoma	2.73e-05	0.000432	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—HBA1—sarcoma	2.72e-05	0.00043	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—SRC—sarcoma	2.72e-05	0.00043	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—SRC—sarcoma	2.72e-05	0.000429	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—EGFR—sarcoma	2.71e-05	0.000428	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—CREB1—sarcoma	2.7e-05	0.000428	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—KRAS—sarcoma	2.7e-05	0.000427	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—HRAS—sarcoma	2.68e-05	0.000424	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—HRAS—sarcoma	2.68e-05	0.000424	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—VEGFA—sarcoma	2.67e-05	0.000423	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PLCG1—sarcoma	2.66e-05	0.000421	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—KRAS—sarcoma	2.65e-05	0.000419	CbGpPWpGaD
Verapamil—ABCC1—Disease—NPM1—sarcoma	2.65e-05	0.000419	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—VEGFA—sarcoma	2.65e-05	0.000418	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—VEGFA—sarcoma	2.64e-05	0.000418	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PLCG1—sarcoma	2.64e-05	0.000418	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—NRAS—sarcoma	2.64e-05	0.000418	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—NRAS—sarcoma	2.61e-05	0.000413	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—NRAS—sarcoma	2.61e-05	0.000413	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—HRAS—sarcoma	2.61e-05	0.000413	CbGpPWpGaD
Verapamil—CACNB2—Neuronal System—HRAS—sarcoma	2.59e-05	0.000409	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—TP53—sarcoma	2.58e-05	0.000408	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—CTNNB1—sarcoma	2.58e-05	0.000407	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—KRAS—sarcoma	2.56e-05	0.000405	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ENO2—sarcoma	2.56e-05	0.000404	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—HBA1—sarcoma	2.54e-05	0.000402	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ENO2—sarcoma	2.52e-05	0.000399	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—HBA1—sarcoma	2.5e-05	0.000396	CbGpPWpGaD
Verapamil—KCNJ11—Neuronal System—HRAS—sarcoma	2.47e-05	0.00039	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ENO2—sarcoma	2.45e-05	0.000388	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—CTNNB1—sarcoma	2.44e-05	0.000386	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—HBA1—sarcoma	2.44e-05	0.000385	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	2.43e-05	0.000384	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—EGFR—sarcoma	2.41e-05	0.00038	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—EGFR—sarcoma	2.38e-05	0.000376	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—EGFR—sarcoma	2.38e-05	0.000376	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—SRC—sarcoma	2.33e-05	0.000368	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—HRAS—sarcoma	2.33e-05	0.000368	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PLCG1—sarcoma	2.32e-05	0.000367	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—HRAS—sarcoma	2.3e-05	0.000363	CbGpPWpGaD
Verapamil—ABCC1—Disease—ENO2—sarcoma	2.29e-05	0.000363	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—KRAS—sarcoma	2.27e-05	0.000359	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—VEGFA—sarcoma	2.27e-05	0.000359	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—HRAS—sarcoma	2.25e-05	0.000356	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—KRAS—sarcoma	2.25e-05	0.000356	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—KRAS—sarcoma	2.25e-05	0.000356	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—NRAS—sarcoma	2.24e-05	0.000354	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—MDM2—sarcoma	2.24e-05	0.000354	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—SRC—sarcoma	2.21e-05	0.000349	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—HRAS—sarcoma	2.18e-05	0.000344	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PLCG1—sarcoma	2.17e-05	0.000343	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—CTNNB1—sarcoma	2.17e-05	0.000343	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—VEGFA—sarcoma	2.15e-05	0.00034	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.15e-05	0.000339	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—CTNNB1—sarcoma	2.14e-05	0.000339	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PLCG1—sarcoma	2.14e-05	0.000338	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ENO2—sarcoma	2.13e-05	0.000338	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—NRAS—sarcoma	2.12e-05	0.000335	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—HBA1—sarcoma	2.12e-05	0.000335	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—HRAS—sarcoma	2.11e-05	0.000334	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PLCG1—sarcoma	2.08e-05	0.000329	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—EGFR—sarcoma	2.04e-05	0.000323	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—SRC—sarcoma	1.96e-05	0.00031	CbGpPWpGaD
Verapamil—ABCC1—Disease—PLCG1—sarcoma	1.95e-05	0.000308	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—SRC—sarcoma	1.94e-05	0.000306	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—EGFR—sarcoma	1.93e-05	0.000306	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—HRAS—sarcoma	1.93e-05	0.000305	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—KRAS—sarcoma	1.93e-05	0.000305	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ENO2—sarcoma	1.92e-05	0.000304	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—HRAS—sarcoma	1.91e-05	0.000302	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—HRAS—sarcoma	1.91e-05	0.000302	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—HBA1—sarcoma	1.91e-05	0.000302	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—VEGFA—sarcoma	1.91e-05	0.000302	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—VEGFA—sarcoma	1.89e-05	0.000298	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—NRAS—sarcoma	1.88e-05	0.000298	CbGpPWpGaD
Verapamil—ABCC1—Disease—CXCR4—sarcoma	1.87e-05	0.000296	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—NRAS—sarcoma	1.86e-05	0.000295	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—IL2—sarcoma	1.84e-05	0.00029	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—KRAS—sarcoma	1.83e-05	0.000289	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ENO2—sarcoma	1.83e-05	0.000289	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—HBA1—sarcoma	1.81e-05	0.000287	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PLCG1—sarcoma	1.81e-05	0.000286	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.78e-05	0.000281	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—EGFR—sarcoma	1.72e-05	0.000271	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—EGFR—sarcoma	1.7e-05	0.000269	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ENO2—sarcoma	1.69e-05	0.000267	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—HBA1—sarcoma	1.68e-05	0.000266	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ENO2—sarcoma	1.68e-05	0.000265	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—HBA1—sarcoma	1.66e-05	0.000263	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—HRAS—sarcoma	1.64e-05	0.000259	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PLCG1—sarcoma	1.63e-05	0.000258	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—KRAS—sarcoma	1.62e-05	0.000256	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—KRAS—sarcoma	1.6e-05	0.000254	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—HRAS—sarcoma	1.6e-05	0.000253	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—SRC—sarcoma	1.6e-05	0.000253	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—VEGFA—sarcoma	1.56e-05	0.000247	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ENO2—sarcoma	1.56e-05	0.000247	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—HRAS—sarcoma	1.55e-05	0.000245	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—HBA1—sarcoma	1.55e-05	0.000245	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PLCG1—sarcoma	1.55e-05	0.000245	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.55e-05	0.000245	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.54e-05	0.000244	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—NRAS—sarcoma	1.54e-05	0.000244	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.53e-05	0.000242	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PLCG1—sarcoma	1.43e-05	0.000227	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PLCG1—sarcoma	1.42e-05	0.000225	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.38e-05	0.000219	CbGpPWpGaD
Verapamil—ABCC1—Disease—FOXO1—sarcoma	1.38e-05	0.000218	CbGpPWpGaD
Verapamil—ABCC1—Disease—PDGFRB—sarcoma	1.38e-05	0.000218	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HRAS—sarcoma	1.38e-05	0.000218	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HRAS—sarcoma	1.36e-05	0.000216	CbGpPWpGaD
Verapamil—ABCC1—Disease—PDGFRA—sarcoma	1.36e-05	0.000215	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.35e-05	0.000213	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—KRAS—sarcoma	1.33e-05	0.00021	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PLCG1—sarcoma	1.32e-05	0.000209	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.24e-05	0.000196	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ENO2—sarcoma	1.24e-05	0.000196	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—HBA1—sarcoma	1.23e-05	0.000195	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—HRAS—sarcoma	1.23e-05	0.000194	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.21e-05	0.000192	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ENO2—sarcoma	1.21e-05	0.000192	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—HBA1—sarcoma	1.2e-05	0.00019	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—sarcoma	1.18e-05	0.000186	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.15e-05	0.000181	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—HRAS—sarcoma	1.13e-05	0.000178	CbGpPWpGaD
Verapamil—ABCC1—Disease—KIT—sarcoma	1.05e-05	0.000166	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PLCG1—sarcoma	1.05e-05	0.000166	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ENO2—sarcoma	1.05e-05	0.000166	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—HBA1—sarcoma	1.04e-05	0.000165	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PLCG1—sarcoma	1.03e-05	0.000162	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.02e-05	0.000161	CbGpPWpGaD
Verapamil—ABCC1—Disease—CREB1—sarcoma	1e-05	0.000158	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ENO2—sarcoma	9.36e-06	0.000148	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HBA1—sarcoma	9.3e-06	0.000147	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ENO2—sarcoma	9.14e-06	0.000145	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HBA1—sarcoma	9.08e-06	0.000144	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PLCG1—sarcoma	8.9e-06	0.000141	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ENO2—sarcoma	8.61e-06	0.000136	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HBA1—sarcoma	8.56e-06	0.000135	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ENO2—sarcoma	8.54e-06	0.000135	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HBA1—sarcoma	8.48e-06	0.000134	CbGpPWpGaD
Verapamil—ABCC1—Disease—MDM2—sarcoma	8.29e-06	0.000131	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PLCG1—sarcoma	7.94e-06	0.000126	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PLCG1—sarcoma	7.75e-06	0.000123	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PLCG1—sarcoma	7.31e-06	0.000116	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ENO2—sarcoma	7.3e-06	0.000115	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HBA1—sarcoma	7.25e-06	0.000115	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PLCG1—sarcoma	7.24e-06	0.000115	CbGpPWpGaD
Verapamil—ABCC1—Disease—CTNNB1—sarcoma	7.15e-06	0.000113	CbGpPWpGaD
Verapamil—ABCC1—Disease—SRC—sarcoma	6.46e-06	0.000102	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRAS—sarcoma	6.22e-06	9.83e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PLCG1—sarcoma	6.19e-06	9.79e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—sarcoma	5.79e-06	9.16e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—sarcoma	5.66e-06	8.95e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ENO2—sarcoma	5.63e-06	8.9e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HBA1—sarcoma	5.6e-06	8.85e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—sarcoma	5.35e-06	8.46e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PLCG1—sarcoma	4.78e-06	7.55e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—sarcoma	4.55e-06	7.19e-05	CbGpPWpGaD
